Kory Wentworth
Financieel Directeur/CFO bij ENTRADA THERAPEUTICS, INC.
Vermogen: 219 884 $ op 30-04-2024
Actieve functies van Kory Wentworth
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ENTRADA THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-11-2020 | - |
Treasurer | 01-11-2020 | - |
Loopbaan van Kory Wentworth
Eerdere bekende functies van Kory Wentworth
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BLUEBIRD BIO, INC. | Comptroller/Controller/Auditor | 18-12-2017 | 08-09-2020 |
Treasurer | 18-12-2017 | 02-10-2020 | |
ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01-11-2017 | 01-12-2017 |
Directeur/Bestuurslid | 01-01-2012 | 01-12-2017 | |
Corporate Officer/Principal | 01-12-2008 | 01-12-2017 |
Opleiding van Kory Wentworth
Susquehanna University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Comptroller/Controller/Auditor | 2 |
Treasurer | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BLUEBIRD BIO, INC. | Health Technology |
ENTRADA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Kory Wentworth
- Ervaring